March 25 (Reuters) - Mesoblast Ltd (MSB) :
- MESOBLAST LICENSEE FILES FOR MARKETING APPROVAL TO TREAT EPIDERMOLYSIS BULLOSA
- Forums
- ASX - By Stock
- MSB
- News: MSB Mesoblast Licensee Files For Marketing Approval To Treat Epidermolysis Bullosa
News: MSB Mesoblast Licensee Files For Marketing Approval To Treat Epidermolysis Bullosa
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.49 |
Change
0.000(0.00%) |
Mkt cap ! $1.113B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1000 | $1.60 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.45 | 400 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2 | 1.375 |
1 | 82 | 1.370 |
1 | 3981 | 1.365 |
7 | 49392 | 1.360 |
1 | 4134 | 1.355 |
Price($) | Vol. | No. |
---|---|---|
1.385 | 247 | 1 |
1.400 | 4328 | 1 |
1.405 | 12000 | 2 |
1.410 | 18724 | 1 |
1.420 | 12000 | 2 |
Last trade - 10.00am 22/11/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |